Availability of vaccines of an assured quality.
In establishing standards of quality for vaccines used in vaccination programmes, it is necessary to protect the recipients without demanding unnecessarily high specifications and standards of purity. Such standards reduce profitability, jeopardizing further vaccine supplies and future research, and also diminish the probability of vaccine manufacture outside the industrialized countries. Funds will be needed to encourage research and local manufacture, and internationally accepted procedures of quality assurance must be established.
Magrath
D I
DI
WHO, Geneva, Switzerland.
D003362:Cost-Benefit Analysis; D011785:Quality Assurance, Health Care; D012306:Risk; D014480:United Nations; D014611:Vaccination / Q000331:legislation & jurisprudence; D014612:Vaccines / Q000191:economics / Q000592:standards* / Q000600:supply & distribution*; D014944:World Health Organization
D014612:Vaccines